Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Tax Provisions (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Tax Provisions data on record, last reported at $5000.0 in Q3 2025.

  • For Q3 2025, Tax Provisions rose 266.67% year-over-year to $5000.0; the TTM value through Dec 2025 reached $7000.0, up 16.67%, while the annual FY2025 figure was $7000.0, 16.67% up from the prior year.
  • Tax Provisions reached $5000.0 in Q3 2025 per TLSI's latest filing, up from -$3000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $42722.0 in Q2 2023 and bottomed at -$5000.0 in Q1 2023.
  • Average Tax Provisions over 4 years is $7160.3, with a median of $4000.0 recorded in 2024.
  • Peak YoY movement for Tax Provisions: crashed 200.0% in 2024, then surged 266.67% in 2025.
  • A 4-year view of Tax Provisions shows it stood at $6000.0 in 2022, then crashed by 83.33% to $1000.0 in 2023, then plummeted by 200.0% to -$1000.0 in 2024, then soared by 600.0% to $5000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $5000.0 in Q3 2025, -$3000.0 in Q2 2025, and $5000.0 in Q1 2025.